PLAU and hepatocellular carcinoma: Given that treatment with LicA inhibits SK-Hep-1 and HA22T/VGH cell migration and invasion through an inhibition of uPA at both the transcriptional and translational level, we attempted to determine the signaling pathways involved in the LicA-induced inhibition of uPA expression in HCC cells.